Increase in life expectancy and population growth in Brazil with impact on the number of people living with chronic-degenerative diseases: challenges for the management of Alzheimer's Disease
DOI:
https://doi.org/10.33448/rsd-v12i5.31673Keywords:
Dementias; Alzheimer's disease; Demographic transition; Incidence; Life expectancy; Brazil.Abstract
Alzheimer's Disease (AD) and other dementias are chronic neurodegenerative diseases that reach a higher incidence in the older population, and these non-communicable chronic diseases may reach alarming numbers with the growth of the Brazilian population and the increase in life expectancy, since over the last decades the exponential increase in the incidence of non-communicable chronic diseases, such as AD, has been an inexorable phenomenon during the epidemiological transition experienced in the country. In fact, this demographic transition has been considered in theories of health actions in the country, however, little has been effectively done in practice, so that there are still various gaps in policies and actions in the field of public health that are aimed at meeting the needs of the population, local epidemiological needs regarding the attention focused on a complex health care network that can reach the most vulnerable elderly populations impacted by non-communicable chronic diseases, since a possible increase implies an increase in the demand for services and these services must be of quality, aiming at the success in the management of patients, the reduction of morbidity and mortality and the implementation of quality of life and a healthier aging for the patient with an associated decrease in disability-adjusted life years (DALY). In this systematic review we analyze the current case of AD in the Brazilian population, focusing on aspects related to the impacts of the demographic transition on the number of people living with this disease.
References
Alzheimer’s Disease International (ADI). (2022). <https://www.alzint.org/resource/numbers-of-people-with-demenetia-worldwide/>.
Amado, D. K., Brucki, S. M. D. (2018). Knowledge about Alzheimer’s disease in the Brazilian population. Arq Neuropsiquiatr. 76(11), 775-782.
Aysegul, U., et al. (2015). Epidemiology of Alzheimer's Disease with the Projection of Falls Among the Aged Population. In: Alzheimer's disease: challenges for the future. IntechOpen. 372 pg.
Barber, R.C. (2012). The Genetics of Alzheimer’s Disease. Scientifica. 2012, Article ID 246210.
Brasil. (1990). Lei 8080 de 19 de setembro de 1990. Lei Orgânica da Saúde. <https://www.planalto.gov.br/ccivil_03/leis/l8080.htm>
Centers for Disease Control and Prevention (CDC). (2022). <https://www.cdc.gov/aging/aginginfo/alzheimers.htm>.
da Costa, G. D., et al. (2019). Educação profissional sobre demências na atenção primária à saúde: revisão integrativa. Rev Bras Enferm [Internet]. 72(4), 1144-52.
Feter, N., et al. (2021). Who are the people with Alzheimer’s disease in Brazil? Findings from the Brazilian Longitudinal Study of Aging. Rev Bras Epidemiol. 24, E210018.
GBD. (2018). Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016. Lancet, 392, 760–75.
GBD. (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 7, e105–25.
Herrera, E., et al. (2002). Epidemiologic Survey of Dementia in a Community-Dwelling Brazilian Population. Alzheimer Disease and Associated Disorders. 16, 103–108.
Ilha, S., et al. (2020). (Geronto)Technologies of care for old people with Alzheimer’s disease and their families: contribution of awareness/training workshops. Rev Bras Geriatr Gerontol. 23(3), e200129.
Leal Cortez, A. C., et al. (2019). Aspectos gerais sobre a transição demográfica e epidemiológica da população brasileira. Enferm Bras. 18(5), 700-9.
Mayeux, R., & Stern, Y. (2012). Epidemiology of Alzheimer Disease. Cold Spring Harb Perspect Med. 2, a006239.
Organização Mundial da Saúde (OMS). (2022). <https://www.who.int/news-room/fact-sheets/detail/dementia>.
Page, M. J., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372 (71), 1-9.
Passos, V. M. A., et al. (2020). The burden of disease among Brazilian older adults and the challenge for health policies: results of the Global Burden of Disease Study 2017. Population Health Metrics. 18(Suppl 1), 14.
Reis, C., et al. (2016). desafio do envelhecimento populacional na perspectiva sistêmica da saúde. BNDES Setorial. 44, 87-124.
Sandoval, J. J., et al. (2019). Adjusted mortality rates attributable to Alzheimer’s disease dementia, Brazil, 2009-2013. Cad Saúde Pública. 35(6), e00091918.
Schramm, J. M. A., et al. (2004). Transição epidemiológica e o estudo de carga de doença no Brasil. Ciência & Saúde Coletiva. 9(4), 897-908, 200.
Sims, R., et al. (2020). The multiplex model of the genetics of Alzheimer’s disease. Nat Neurosci. 23, 311–322.
Teixeira, J. B., et al. (2015). Doença de Alzheimer: estudo da mortalidade no Brasil, 2000-2009. Cad Saúde Pública. 31(4), 1-12.
Ximenes, M. A., et al. Doença de Alzheimer: a dependência e o cuidado. Revista Kairós Gerontologia. 17(2), 121-140.
Zissimopoulos, J. M., et al. (2018). The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer’s Disease and Other Dementias in the United States. J Gerontol B Psychol Sci Soc Sci. 73, S38–S47.
Wolters, F. J., et al. (2020). Twenty-seven-year time trends in dementia incidence in Europe and the United States. Neurology. 95, e519-e531.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Wandyk Allisson Bernardes Pereira; Igor Rodrigues de Oliveira; Fabrício Werner; Lucas Tomio dos Santos; Pedro Silveira Furtado; Renan Vilela Brigagão; Ana Júlia Schnorr Mayer; Cláudio Daniel Cerdeira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
